MOLECULAR ONCOLOGY[ta] - Search Results

Year	Number of Results
2007	40
2008	59
2009	54
2010	51
2011	65
2012	90
2013	131
2014	212
2015	210
2016	137
2017	132
2018	160
2019	204
2020	270
2021	315
2022	266
2023	234
2024	110

1

Protein palmitoylation in cancer: molecular functions and therapeutic potential.

Zhou B, Hao Q, Liang Y, Kong E. Zhou B, et al. Mol Oncol. 2023 Jan;17(1):3-26. doi: 10.1002/1878-0261.13308. Epub 2022 Sep 10. Mol Oncol. 2023. PMID: 36018061 Free PMC article. Review.

2

Cellular senescence and the tumour microenvironment.

Takasugi M, Yoshida Y, Ohtani N. Takasugi M, et al. Mol Oncol. 2022 Sep;16(18):3333-3351. doi: 10.1002/1878-0261.13268. Epub 2022 Jun 26. Mol Oncol. 2022. PMID: 35674109 Free PMC article. Review.

3

Resistance to DNA repair inhibitors in cancer.

Baxter JS, Zatreanu D, Pettitt SJ, Lord CJ. Baxter JS, et al. Mol Oncol. 2022 Nov;16(21):3811-3827. doi: 10.1002/1878-0261.13224. Epub 2022 Jun 5. Mol Oncol. 2022. PMID: 35567571 Free PMC article. Review.

4

Palliative oncology and palliative care.

Strang P. Strang P. Mol Oncol. 2022 Oct;16(19):3399-3409. doi: 10.1002/1878-0261.13278. Epub 2022 Aug 12. Mol Oncol. 2022. PMID: 35762045 Free PMC article.

5

Molecular Oncology and the EACR: new partners in communicating and supporting cancer research.

Ryan KM, Smith J, Bernards R. Ryan KM, et al. Mol Oncol. 2023 Jun;17(6):919-920. doi: 10.1002/1878-0261.13445. Mol Oncol. 2023. PMID: 37300661 Free PMC article.

6

Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.

Gulley JL, Schlom J, Barcellos-Hoff MH, Wang XJ, Seoane J, Audhuy F, Lan Y, Dussault I, Moustakas A. Gulley JL, et al. Mol Oncol. 2022 Jun;16(11):2117-2134. doi: 10.1002/1878-0261.13146. Epub 2022 Jan 4. Mol Oncol. 2022. PMID: 34854206 Free PMC article. Review.

7

EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries.

Elshatlawy M, Sampson J, Clarke K, Bayliss R. Elshatlawy M, et al. Mol Oncol. 2023 Jun;17(6):950-963. doi: 10.1002/1878-0261.13446. Epub 2023 May 15. Mol Oncol. 2023. PMID: 37149843 Free PMC article. Review.

8

Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.

Wang T, Dang N, Tang G, Li Z, Li X, Shi B, Xu Z, Li L, Yang X, Xu C, Ye K. Wang T, et al. Mol Oncol. 2022 Jun;16(11):2195-2213. doi: 10.1002/1878-0261.13190. Epub 2022 Mar 1. Mol Oncol. 2022. PMID: 35124891 Free PMC article.

9

Navigating the current landscape of scientific publishing - the Molecular Oncology perspective.

Ryan KM. Ryan KM. Mol Oncol. 2022 Jun;16(12):2297-2299. doi: 10.1002/1878-0261.13271. Mol Oncol. 2022. PMID: 35723239 Free PMC article. No abstract available.

10

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma.

Liu K, Geng Y, Wang L, Xu H, Zou M, Li Y, Zhao Z, Chen T, Xu F, Sun L, Wu S, Gu Y. Liu K, et al. Mol Oncol. 2022 Aug;16(16):3034-3051. doi: 10.1002/1878-0261.13279. Epub 2022 Jul 22. Mol Oncol. 2022. PMID: 35810469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,226 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,226 results

Results by year